推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33363733,021-34612310

chinasupport@letpub.com

登录 注册 新注册优惠

CLINICAL DRUG INVESTIGATION

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 CLIN DRUG INVES最新评论:已经2周了 (2024-01-04)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


CLINICAL DRUG INVESTIGATION期刊基本信息Hello,您是该期刊的第19125位访客


基本信息 登录收藏
期刊名字CLINICAL DRUG INVESTIGATIONCLINICAL DRUG INVESTIGATION

CLIN DRUG INVEST
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
5.2
50人评分
我要评分

声誉
6.4

影响力
3.9

速度
7.0

期刊ISSN1173-2563
微信扫码收藏此期刊
E-ISSN1179-1918
2023-2024最新影响因子
(数据来源于搜索引擎)
2.9 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:2.778
2023-2024自引率3.40%点击查看自引率趋势图
五年影响因子2.5
JCI期刊引文指标 0.8
h-index 53
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
5.900.6800.798
学科分区排名百分位
大类:Medicine
小类:Pharmacology (medical)
Q281 / 272

期刊简介
Clinical Drug Investigation provides rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. The Journal includes:

-Clinical trials, outcomes research, clinical pharmacoeconomic studies and pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs.
-Clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice.

-Pharmacodynamic and pharmacokinetic studies in healthy volunteers in which significant implications for clinical prescribing are discussed.

-Studies focusing on the application of drug delivery technology in healthcare.

-Short communications and case study reports that meet the above criteria will also be considered.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Clinical Drug Investigation may be accompanied by plain language summaries to assist readers who have some knowledge, but non in-depth expertise in, the area to understand important medical advances.
期刊官方网站https://www.springer.com/40261
期刊投稿网址https://www.editorialmanager.com/cdia/
作者指南网址https://www.springer.com/40261/submission-guidelines
期刊语言要求Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CLINICAL DRUG INVESTIGATION的语言要求,还能让CLINICAL DRUG INVESTIGATION编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CLINICAL DRUG INVESTIGATION编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式ADIS INT LTD, 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND, NEW ZEALAND, 1311
出版商Springer International Publishing
涉及的研究方向医学-药学
出版国家或地区NEW ZEALAND
出版语言English
出版周期Monthly
出版年份1989
年文章数 85点击查看年文章数趋势图
Gold OA文章占比44.96%
研究类文章占比:
文章 ÷(文章 + 综述)
76.47%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:2区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:PHARMACOLOGY & PHARMACYSCIEQ2147/354
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:PHARMACOLOGY & PHARMACYSCIEQ2125/354
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区3区4区
PHARMACOLOGY & PHARMACY
药学
3区3区3区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 2区3区1区
PHARMACOLOGY & PHARMACY
药学
2区4区3区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 3区4区2区
PHARMACOLOGY & PHARMACY
药学
3区4区4区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1173-2563%5BISSN%5D
平均审稿速度网友分享经验:
较慢,6-12周
平均录用比例网友分享经验:
较易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在CLINICAL DRUG INVESTIGATION顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 CLINICAL DRUG INVESTIGATION期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 CLINICAL DRUG INVESTIGATION中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
CLINICAL DRUG INVESTIGATION上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    PHARMACOLOGICAL REVIEWS21034.70
    DRUG RESISTANCE UPDATES10026.20
    ADVANCED DRUG DELIVERY REVIEWS27828.10
    TRENDS IN PHARMACOLOGICAL SCIENCES20123.90
    PHARMACOLOGY & THERAPEUTICS18023.00
    MEDICINAL RESEARCH REVIEWS11929.30
    PHARMACOLOGICAL RESEARCH11818.70
    ARCHIVES OF PHARMACAL RESEARCH7513.40
    BIOMEDICINE & PHARMACOTHERAPY7811.90
    BRITISH JOURNAL OF PHARMACOLOGY19015.40
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE659902
    BIOMATERIALS555259
    BIOMEDICINE & PHARMACOTHERAPY533368
    Frontiers in Pharmacology501271
    Journal of Materials Chemistry B492738
    Frontiers in Immunology477087
    COMPUTERS IN BIOLOGY AND MEDICINE453816
    JOURNAL OF ETHNOPHARMACOLOGY452031
    COLLOIDS AND SURFACES B-BIOINTERFACES430979
    Frontiers in Oncology425079
  •  

    CLINICAL DRUG INVESTIGATION CLINICAL DRUG INVESTIGATION
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Therapeutic Polypeptides and Peptidomimetics: Powerful Tools for COVID-19 Treatment

    Author: Liu, Xinyu; Shi, Jian; Wang, Deyang; Su, Ying; Xing, Zhen; Sun, Fei; Chen, Fei
    Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. 43, Issue 1, pp. 13-22. DOI: 10.1007/s40261-022-01231-w
        PubMed      DOI
    2.Safety and Efficacy of Edaravone in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis

    Author: Gao, Mengxia; Zhu, Lingqun; Chang, Jingling; Cao, Tianyu; Song, Lianying; Wen, Chunli; Chen, Yi; Zhuo, Yudi; Chen, Fei
    Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. 43, Issue 1, pp. 1-11. DOI: 10.1007/s40261-022-01229-4
        PubMed      DOI
    3.Pharmacokinetics and Safety of Follitropin Delta in Gonadotropin Down-Regulated Healthy Chinese Women

    Author: Shao, Feng; Jiang, Yi; Ding, Sijia; Larsson, Per; Pinton, Philippe; Jonker, Daniel Martijn
    Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. 43, Issue 1, pp. 37-44. DOI: 10.1007/s40261-022-01232-9
        PubMed      DOI
    4.A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case-Control Study

    Author: Deng, Haiyi; Deng, Jiating; Lin, Xinqing; Guan, Wenhui; Lin, Ziying; Qiu, Yanli; Yang, Yilin; Wu, Jianhui; Qiu, Guihuan; Sun, Ni; Zhou, Maolin; Deng, Jiaxi; Xie, Xiaohong; Xie, Zhanhong; Liu, Ming; Qin, Yinyin; Zhou, Yanbin; Zhou, Chengzhi
    Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40261-023-01267-6
        PubMed      DOI
    5.A Single- and Multiple-Dose Pharmacokinetic Study of Oral Perampanel in Healthy Chinese Subjects

    Author: Jing, Shan; Shiba, Sari; Morita, Masafumi; Yasuda, Sanae; Lin, Yang
    Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. 43, Issue 3, pp. 155-165. DOI: 10.1007/s40261-022-01241-8
        PubMed      DOI
    6.Efficacy of Eltrombopag with Immunosuppressive Therapy Versus Immunosuppressive Therapy Alone on Severe Aplastic Anaemia: A Systematic Review and Meta-analysis

    Author: Zhang, Senlin; Wang, Qingwei; Cui, Kai; Cheng, Bingjie; Fan, Junjie; Hu, Shaoyan
    Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40261-023-01266-7
        PubMed      DOI
    7.Vericiguat for the Treatment of Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event: A Cost-Effectiveness Analysis from the Perspective of Chinese Healthcare Providers

    Author: Yu, Xiangyou; Hao, Yan; Zhu, Zhanfang; Zhang, Wei; Liu, Bo; Ma, Meijuan; Zhang, Xuejun; Wei, Na; Wang, Junkui; Liu, Fuqiang
    Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40261-023-01253-y
        PubMed      DOI
    8.A Cost-effectiveness Analysis of iGlarLixi Versus IDegAsp and Appropriate Price Exploration of iGlarLixi for Type 2 Diabetes Mellitus Patients in China

    Author: Jiang, Yanqing; Liu, Ruizhe; Xuan, Jianwei; Lin, Sisi; Zheng, Qiang; Pang, Jianxin
    Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40261-023-01255-w
        PubMed      DOI
    9.Sacubitril/Valsartan for Heart Failure with Preserved Ejection Fraction: A Cost-Effectiveness Analysis from the Perspective of the Chinese Healthcare System

    Author: Wang, Zhe; Lou, Yake; Wang, Qi; Sun, Min; Li, Xiaonan; Wang, Yinghui; Wang, Yuehui
    Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40261-023-01249-8
        PubMed      DOI
    10.Risk of Urinary Tract Infection in Patients with Type 2 Diabetes Mellitus Treated with Dapagliflozin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Author: Zheng, Zhigui; He, Dongyuan; Chen, Jianguo; Xie, Xiaohui; Lu, Yunan; Wu, Binbin; Jiang, Xinxin
    Journal: CLINICAL DRUG INVESTIGATION. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40261-023-01256-9
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Computational Visual Media016.90
    Industrial and Organizational Psychology-Perspectives on Science and Practice07.70
    COMMUNICATIONS OF THE ACM18916.10
    MedComm06.70
    Journal of Econometrics1358.60
    CLINICAL NUCLEAR MEDICINE532.90
    Journal of International Financial Management & Accounting09.10
    BMJ Evidence-Based Medicine08.90
    ARCHIVOS DE BRONCONEUMOLOGIA413.50
    ARCHIVOS DE BRONCONEUMOLOGIA463.50
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共15


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室